
, a German venture capital firm, launched Europe’s first “European Circular Bioeconomy Fund (ECBF)”. Now, the first €82M financing round of the fund has been realized. Amongst the investors is the Dr. Hettich Beteiligungen GmbH, the single family office of the German Hettich family.European Circular Bioeconomy Fund (ECBF)ECBF focuses on the European bioeconomy and the circular bioeconomy. The fund was initiated by a team around Michael Brandkamp, Michael Nettersheim and Dirk Saßmannshausen. All General Partners of the new fund were former emplyoees of German VC fund HTGF. Already two investments – in PeelPioneers B.V. and Proloupin GmbH – were made by ECBF. Prolupin is a spin-off from German Frauenhofer Institut that works on lupine-based products. PeelPioneers recycles orange peels to food ingredients.Investment by Hettich single family office from Herford, GermanyThe new European Circular Bioeconomy Fund raised a first round of €82M. Investors are the European Investment Bank, PreZero, Corbion and Dr. Hettich Beteiligungen GmbH. Dr. Hettich Beteiligungen GmbH is the single family office of Dr. Andreas Hettich, the majority shareholder of the Hettich Group, a global leader in furniture fittings. The Hettich family office focues on innovative and sustainable industrial companies.
Source: Picture source: via UnsplashRelevant family office articlesYou also might like researchgermany.com’s about sales in Germany.Relevant family office lists Rated 4.00 out of 5 €399,99 including VAT Rated 5.00 out of 5 €299,99 including VAT Rated 4.67 out of 5 €1.499,99 including VAT Rated 5.00 out of 5 €699,99 including VAT
User Comments1. G.
Carter: Comment sample 1...2. Abigail
Jones: Comment sample 2...3. B.
King: Comment sample 3...4. William Lee: Comment sample 4...5. Matthew M.: Comment sample 5...Editor's NoteThis article was refined for clarity, structure, and user experience.

(Editors: admin)
Disclaimer & Copyright Notice:
This article is edited and compiled by the editorial team at WealthShield Asia based on publicly available information. It is intended for informational purposes only and does not constitute legal, financial, or investment advice.
We respect intellectual property rights. If you believe that any part of this article infringes upon your copyright or other legal rights, please contact us at
admin@wealthshield.asia. We will promptly review and remove the content if necessary.
All rights reserved. Unauthorized reproduction or redistribution is prohibited.